Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers.
Curr Opin Rheumatol., Mar;24(2):165-70 (2012)
Osteopontin in systemic sclerosis and its role in dermal fibrosis.
J. Invest. Dermatol., Jun;132(6):1605-14 (2012)
IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.
Ann. Rheum. Dis., Jul;71(7):1197-202 (2012)
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort.
Arthritis Res. Ther., 12(5):R166 (2010)
Whole-blood gene expression profiling in ankylosing spondylitis shows upregulation of toll-like receptor 4 and 5.
J. Rheumatol., Jan;38(1):87-98 (2011)
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblasts.
Arthritis Res. Ther., 13(1):R3 (2011)
Determinants of work disability in patients with systemic sclerosis: a longitudinal study of the GENISOS cohort.
Semin. Arthritis Rheum., Aug;41(1):38-47 (2011)
Anti-fibrillarin antibody in African American patients with systemic sclerosis: immunogenetics, clinical features, and survival analysis.
J. Rheumatol., Aug;38(8):1622-30 (2011)
Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.
Arthritis Rheum., Dec;60(12):3794-806 (2009)
Separate influences of birth order and gravidity/parity on the development of systemic sclerosis.
Arthritis Care Res (Hoboken)., Mar;62(3):418-24 (2010)
Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients.
J. Rheumatol., Oct;36(10):2250-6 (2009)
Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis.
Ann. Rheum. Dis., Mar;69(3):550-5 (2010)
Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.
Ann. Rheum. Dis., May;69(5):822-7 (2010)
Clinical and genetic factors predictive of mortality in early systemic sclerosis.
Arthritis Rheum., Oct;61(10):1403-11 (2009)
Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations.
J. Autoimmun., Mar;34(2):155-62 (2010)
Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis.
J. Rheumatol., Dec;36(12):2715-23 (2009)
Plasma cytokine profiles in systemic sclerosis: associations with autoantibody subsets and clinical manifestations.
Arthritis Res. Ther., 11(5):R147 (2009)
An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis.
Rheumatology (Oxford)., Aug;46(8):1248-51 (2007)
Clinical, immunologic, and genetic features of familial systemic sclerosis.
Arthritis Rheum., Jun;56(6):2031-7 (2007)
Genetic factors in systemic sclerosis.
Arthritis Res. Ther., 9 Suppl 2:S5 (2007)